Tamás Révész

Women's and Children's Hospital — Australia

Medicine · Health Sciences

22h-index1.7kcitations110works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(61), Childhood Cancer Survivors' Quality of Life(27), Acute Myeloid Leukemia Research(16), Chronic Myeloid Leukemia Treatments(16), Hematopoietic Stem Cell Transplantation(9)

Publications110 total

Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond Treatment
Cancers·2025· 4 citedOpen Access
Natural history and neuropathology of patients presenting with pure autonomic failure
2023
Late effects in survivors of infant acute lymphoblastic leukaemia—a study of the Australian and New Zealand Children’s Haematology/Oncology Group
Blood Cancer Journal·2023· 4 citedOpen Access
Supplementary Table S2 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Figures S1-S9 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S1 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S1 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S7 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Figures S1-S9 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S3 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Figure Legends from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Methods and References from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S3 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S2 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S4 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Figure Legends from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S6 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Methods and References from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Data from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
Supplementary Table S7 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Rosemary Sutton(23), Nicola C. Venn(11), Frank Alvaro(11), Glenn M. Marshall(11), Michael Osborn(10), Toby N. Trahair(8), Deborah L. White(8), Catriona Parker(7), Vaskar Saha(7), Tamara Law(7), Peter M. Hoogerbrugge(7), Murray D. Norris(7), Luciano Dalla‐Pozza(6), Ram Suppiah(6), Susan L. Heatley(6), Marion K. Mateos(6), Rishi S. Kotecha(6), Heather Tapp(6), Jeremy Hancock(5), Anthony V. Moorman(5)